In the modern era of science, clinical trial design has become a crucial component of drug development. The so-called ‘gold standard’ drug trial involves more than a hundred subjects who receive a new drug and are followed for a period. As industry leader Obviohealth explains (https://www.obviohealth.com/resources/decentralized-clinical-trials-a-comprehensive-synopsis), the trial isn’t just used to test the effectiveness of a drug when used alone, but also in combination with other treatments.
In this post, we’ll discuss how to design a hybrid clinical trial to get the best results from your research project.
What is a Hybrid Clinical Trial
You might have heard about the hybrid approach to clinical trials, but what does it mean? These types of clinical trials combine traditional and virtual study methods. A portion of the research in a hybrid trial requires the use of wearables, mobile phones and other devices to gather data. The remaining studies are conventional; that means engaging with the study staff in person.
Traditional clinical trials have been the norm for a long time, but they had several barriers to participation that virtual or remote studies solve. Conducting clinical trials remotely means participants who can’t get to study sites still have a chance to provide data through various remote monitoring devices. This approach ensures a more inclusive study than a strictly conventional clinical trial. Participants with mobility challenges can provide data without any issues. The COVID-19 pandemic was a big driver of the adoption of virtual technology in clinical research.
Difference between Hybrid and Decentralised Clinical Studies
Some researchers interchange decentralised and hybrid to explain research that merged virtual and traditional approaches. However, the two methods are slightly different. A decentralised study brings study centres closer to the people. Its main aim is to eliminate the burden of travel. Therefore, patients don’t have to visit central locations to submit information.
Researchers use virtual resources to collect data. However, decentralised studies are not all virtual. Patients can still interact with researchers in person, except they don’t have to travel too far for that. This clinical trial might require partnerships with local doctors, caregivers and mobile health networks.
You might wonder if that isn’t how a hybrid clinical study works. The similarities between hybrid and decentralised designs are clear. However, a hybrid approach doesn’t necessarily involve bringing study sites to the patient. The traditional research element in this trial technique can still have in-person visits that require travel.
What to Consider in a Hybrid Clinical Trial
The design of a research study lays the foundation for how everything happens throughout that period. Hence, it determines the success of the entire trial. Most researchers are new to decentralised and virtual clinical trials. So, knowing a few aspects of designing a hybrid study is crucial.
Patient Safety
An extensive safety management plan has to be in place when implementing a hybrid clinical study. You must ensure patients are safe, particularly those receiving medication at home. The safety protocols must address all the possible scenarios a patient might face, and everyone involved should know what to do in certain circumstances.
Face-to-Face Interaction Matters
Even as you incorporate virtual elements in your clinical study, keep in mind that in-person engagement is still vital. Some patients, especially older generations, still believe in face-to-face interactions with healthcare providers. Therefore, consider allowing participants to see doctors and other staff in person. Face-to-face meetings can be for only some of the visits.
Cost
The technologies used for the virtual part of a hybrid trial can cost a pretty penny. You might have to get a lot of new devices, some of which are not designed to scale. When putting together a hybrid or decentralised study, ensure the budget can support the project until completion.
A Country’s Approval
In cases where trial participants are from different countries, you must consider the necessary approvals for hybrid clinical studies. Some regulatory bodies don’t mind how pharmaceutical companies conduct their research as long as they adhere to safety standards and provide quality data. Nonetheless, be sure about the provisions for virtual and decentralised trials.
Hybrid and decentralised clinical studies are slowly becoming a critical part of the pharmaceutical industry. Recently, the sector has been working towards being more patient-centric, and hybrid studies contribute to that. Executing a hybrid clinical trial to maximum efficiency demands you factor in various elements to leverage the benefits offered. A well-designed hybrid research study should take the best of traditional and virtual trial models.
- Agile Practitioner Certification for Data Center Teams: Accelerating Infrastructure Projects - May 2, 2026
- Contact Center Testing for High-Performance Infrastructure: Ensuring Scalability and Reliability - May 1, 2026
- Digital Transformation Conference Insights: What Enterprise Leaders Need to Know - April 13, 2026